关注
Martijn van der Heijden
Martijn van der Heijden
未知所在单位机构
在 nki.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer
M Bogowicz, A Jochems, TM Deist, S Tanadini-Lang, SH Huang, B Chan, ...
Scientific reports 10 (1), 4542, 2020
612020
Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri) tumoral tissue for the prediction of locoregional recurrence and distant …
S Keek, S Sanduleanu, F Wesseling, R De Roest, M Van Den Brekel, ...
PLoS One 15 (5), e0232639, 2020
392020
Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
M van der Heijden, FG Dikkers, GB Halmos
European Archives of Oto-Rhino-Laryngology 273, 1507-1513, 2016
392016
The groningen laryngomalacia classification system—based on systematic review and dynamic airway changes
M van der Heijden, FG Dikkers, GB Halmos
Pediatric pulmonology 50 (12), 1368-1373, 2015
292015
Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck …
CVM Verhagen, DM Vossen, K Borgmann, F Hageman, R Grénman, ...
Oncotarget 9 (26), 18198, 2018
262018
The influence of mechanical bowel preparation on long-term survival in patients surgically treated for colorectal cancer
HP van't Sant, A Kamman, WCJ Hop, M Van Der Heijden, JF Lange, ...
The American Journal of Surgery 210 (1), 106-110, 2015
252015
Biological determinants of chemo-radiotherapy response in HPV-negative head and neck cancer: a multicentric external validation
M Van der Heijden, PBM Essers, MC De Jong, RH De Roest, ...
Frontiers in oncology 9, 1470, 2020
232020
Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 …
CM Gant, AW Rosingh, JL López-Hontangas, M Van der Heijden, ...
Antimicrobial agents and chemotherapy 56 (9), 4988-4989, 2012
232012
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy
M van der Heijden, PBM Essers, CVM Verhagen, SM Willems, J Sanders, ...
Radiotherapy and Oncology 147, 186-194, 2020
162020
Acute hypoxia profile is a stronger prognostic factor than chronic hypoxia in advanced stage head and neck cancer patients
M Van Der Heijden, MC De Jong, CVM Verhagen, RH De Roest, ...
Cancers 11 (4), 583, 2019
162019
Genetic factors associated with a poor outcome in head and neck cancer patients receiving definitive chemoradiotherapy
DM Vossen, CVM Verhagen, M Van Der Heijden, PBM Essers, ...
Cancers 11 (4), 445, 2019
162019
Drug sensitivity prediction models reveal a link between DNA repair defects and poor prognosis in HNSCC
PBM Essers, M Van Der Heijden, CVM Verhagen, EM Ploeg, ...
Cancer research 79 (21), 5597-5611, 2019
142019
Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
PBM Essers, M van der Heijden, D Vossen, RH de Roest, CR Leemans, ...
International journal of cancer 147 (6), 1732-1739, 2020
92020
OC-0487: EMT signatures as a prognostic marker for metastasis in HPV-negative HNSCC
M Van der Heijden, P Essers, M Verheij, M Van den Brekel, C Vens
Radiotherapy and Oncology 127, S250-S251, 2018
32018
Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri) tumoral tissue for the prediction of locoregional recurrence and …
S Keek, S Sanduleanu, F Wesseling, R de Roest, M van den Brekel, ...
Plos one 15 (7), e0237048, 2020
22020
PD-0543: An externally validated prognostic CT radiomics model for head and neck cancer patients
S Keek, S Sanduleanu, HC Woodruff, F Wesseling, D Mattavelli, ...
Radiotherapy and Oncology 152, S301-S302, 2020
2020
OC-0463: In vitro prediction of DNA repair defects reveals association with poor clinical outcome in HNSCC
P Essers, C Verhagen, M Van der Heijden, M Van den Brekel, H Bartelink, ...
Radiotherapy and Oncology 123, S246-S247, 2017
2017
Etiological factors, best treatment and types of laryngomalacia, a retrospective study.
M van der Heijden
2014
534 Serotype Distribution of Invasive Pneumococcal Disease in Infants in the Comunidad Valenciana (5 Million Inhabitants), Spain, 2007-2010
M Van Der Heijden, A Rosingh, E Canton, F Gonzalez, M Gobernado
Pediatric Research 68 (1), 273-273, 2010
2010
系统目前无法执行此操作,请稍后再试。
文章 1–19